Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus - Reply

被引：0

作者：

Gress, TW ^{[1
]}

Brancati, FL ^{[1
]}

机构：

[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2000年 / 343卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：580 / 580

页数：1

相关论文

共 3 条

[1] Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients - Results from the National Cooperative Cardiovascular Project [J].

Chen, J ;

Marciniak, TA ;

Radford, MJ ;

Wang, Y ;

Krumholz, HM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (05) :1388-1394

[2] Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension - A randomized, controlled trial [J].

Giugliano, D ;

Acampora, R ;

Marfella, R ;

DeRosa, N ;

Ziccardi, P ;

Ragone, R ;

DeAngelis, L ;

DOnofrio, F .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :955-959

[3] Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction [J].

Gottlieb, SS ;

McCarter, RJ ;

Vogel, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (08) :489-497